Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.

Mo, Hanjie; Renna, Catherine E; Moore, Halle C F; Abraham, Jame; Kruse, Megan L; Montero, Alberto J; LeGrand, Susan B; Wang, Lu; Budd, G Thomas

Mo, Hanjie; Renna, Catherine E; Moore, Halle C F; Abraham, Jame; Kruse, Megan L; Montero, Alberto J; LeGrand, Susan B; Wang, Lu; Budd, G Thomas.

Afiliación

Mo H; Department of Pharmacy, Cleveland Clinic, Cleveland, OH. Electronic address: hanjiemo@gmail.com.
Renna CE; Department of Pharmacy, Cleveland Clinic, Cleveland, OH.
Moore HCF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Abraham J; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Kruse ML; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Montero AJ; Department of Medical Oncology, University Hospitals Seidman, Cancer Center, Cleveland, OH.
LeGrand SB; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Wang L; Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH.
Budd GT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

Clin Breast Cancer ; 22(2): 143-148, 2022 02.

Article en En | MEDLINE | ID: mdl-34740541

Asunto(s)

Androstadienos/uso terapéutico; Antineoplásicos/uso terapéutico; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/metabolismo; Everolimus/uso terapéutico; Receptor ErbB-2/metabolismo; Adolescente; Adulto; Anciano; Neoplasias de la Mama/patología; Femenino; Humanos; Persona de Mediana Edad; Calidad de Vida; Receptor ErbB-2/efectos de los fármacos; Estudios Retrospectivos; Resultado del Tratamiento

Palabras clave

Breast cancer; CDK4/6 inhibitor; Everolimus; Exemestane; Hormone positive

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Everolimus / Androstadienos / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google